SCHEMBL1171017

SCHEMBL1171017

CC(S)C(=O)O.CC(S)C(=O)O.CC(S)C(=O)O.CC(S)C(=O)O.CC(S)C(=O)O.CC(S)C(=O)O.OCC(CO)(CO)COCC(CO)(CO)CO

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNPEP Q9H4A4 2/20 0.35
ACE P12821 1/20 0.33
ALDH1A1 P00352 2/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
PTGS2 P35354 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
TP53 P04637 1/20 0.31
CYP3A4 P08684 1/20 0.31
MAPK1 P28482 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HIF1A Q16665 1/20 0.31
GABRR1 P24046 2/20 0.31
CYP1A2 P05177 1/20 0.31
FOLH1 Q04609 1/20 0.31
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
MMP3 P08254 1/20 0.31
MMP9 P14780 1/20 0.31
MMP13 P45452 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16536081 1.00 RNPEP (0.35) RNPEPACEALDH1A1LMNAMAPT
SCHEMBL28601727 0.87 GABRR1 (0.33) ALDH1A1TDP1TP53CYP3A4MAPK1
Lactic Acid SCHEMBL28444410 0.85 TP53 (0.48) ALDH1A1TDP1TP53CYP3A4MAPK1
SCHEMBL1171013 0.84 RNPEP (0.42) RNPEPACEALDH1A1LMNAMAPT
SCHEMBL29366714 0.84 RNPEP (0.42) RNPEPACEALDH1A1LMNAMAPT
SCHEMBL467265 0.84 RNPEP (0.42) RNPEPACEALDH1A1LMNAMAPT
SCHEMBL16536080 0.84 RNPEP (0.42) RNPEPACEALDH1A1LMNAMAPT
SCHEMBL4967302 0.84 RNPEP (0.42) RNPEPACEALDH1A1LMNAMAPT
SCHEMBL3095001 0.82 RNPEP (0.37) RNPEPTDP1MAPK1FOLH1
SCHEMBL1171217 0.82 FOLH1 (0.41) MAPTCYP1A2FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658700-A1 ADHESIVE FORMULATION Chemence, Inc (US) 2025-12-10 EP claimed
EP-3101070-B1 INK COMPOSITION FOR INK-JET RECORDING, METHOD OF INK-JET RECORDING, AND PRINTED ARTICLE FUJIFILM CORP (JP) 2020-04-22 EP claimed
EP-3000854-B1 POLYMERIZABLE COMPOSITION, INK COMPOSITION FOR INK-JET RECORDING, METHOD OF INK-JET RECORDING, AND PRINTED ARTICLE FUJIFILM CORP (JP) 2020-03-04 EP claimed
EP-3000851-B1 INK COMPOSITION FOR INKJET RECORDING, INKJET RECORDING METHOD, AND PRINTED MATTER FUJIFILM CORP (JP) 2017-03-08 EP claimed
EP-3101070-A1 POLYMERIZABLE COMPOSITION, INK COMPOSITION FOR INK-JET RECORDING, METHOD OF INK-JET RECORDING, AND PRINTED ARTICLE Fujifilm Corporation (JP) 2016-12-07 EP claimed
US-9441127-B2 Polymerizable composition, ink composition for ink-jet recording, method of ink-jet recording, and printed article FUJIFILM CORPORATION (JP) 2016-09-13 US claimed
EP-2801586-B1 Casting resin on a polythiourethane basis with high tensile strength and low specific weight BRUNO BOCK CHEM FAB GMBH & CO KG (DE) 2016-04-13 EP claimed
US-20160090494-A1 POLYMERIZABLE COMPOSITION, INK COMPOSITION FOR INK-JET RECORDING, METHOD OF INK-JET RECORDING, AND PRINTED ARTICLE FUJIFILM CORPORATION (JP) 2016-03-31 US claimed
EP-3000854-A1 POLYMERIZABLE COMPOSITION, INK COMPOSITION FOR INK-JET RECORDING, METHOD OF INK-JET RECORDING, AND PRINTED ARTICLE Fujifilm Corporation (JP) 2016-03-30 EP claimed
US-12637544-B2 UV curable silicone composition and cured product thereof DUROPTIX MATERIALS KABUSHIKI KAISHA (JP) 2026-05-26 US disclosed
US-12624279-B2 Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device FUJIFILM CORPORATION (JP) 2026-05-12 US disclosed
EP-4703778-A1 WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE Dai Nippon Printing Co., Ltd. (JP) 2026-03-04 EP disclosed
US-12565548-B2 Compound, polymerizable composition, and cured product FUJIFILM CORPORATION (JP) 2026-03-03 US disclosed
EP-4202505-B1 BARRIER FILM, AND WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE IN WHICH SAME IS USED, AS WELL AS METHOD FOR SELECTING BARRIER FILM DAINIPPON PRINTING CO LTD (JP) 2026-02-18 EP disclosed
US-20070161728-A1 Organic Thiol Stabilizers and Plasticizers for Halogen-Containing Polymers COLLEGE OF WILLIAM AND MARY (US) 2007-07-12 US disclosed
US-20070083012-A1 Curable polymer compound SHOWA DENKO K.K. (JP) 2007-04-12 US disclosed
US-20070021571-A1 Curable polymer compound SHOWA DENKO K.K. (JP) 2007-01-25 US disclosed
US-20060041053-A1 Color filter black matrix resist composition and carbon black dispersion composition used for the composition SHOWA DENKO K.K. (JP) 2006-02-23 US disclosed
US-20060036023-A1 Color filter black matrix resist composition SHOWA DENKO K.K. (JP) 2006-02-16 US disclosed
US-20050153231-A1 Thiol compound, photopolymerization initiator composition and photosensitive composition SHOWA DENKO K.K. (JP) 2005-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12637544-B2 UV curable silicone composition and cured product thereof QSOX1, MGMT, TST RNPEP 4474/4885ACE 2897/4885ALDH1A1 70/4885
US-12624279-B2 Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device NLRP1, NLRP3, ALAD RNPEP 4325/4885ACE 3176/4885ALDH1A1 45/4885
US-12565548-B2 Compound, polymerizable composition, and cured product SEM1, PSMA1, RER1 RNPEP 4646/4885ACE 4668/4885ALDH1A1 1138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.